SCHEDULE: Migdal Insurance Discloses TAT Technologies Stake
Beneficial Ownership Disclosure
Migdal Insurance & Financial Holdings Ltd. and its subsidiaries have reported a combined beneficial ownership of 7.27% in TAT Technologies Ltd. as of June 30, 2026.
Summary
- Migdal Insurance & Financial Holdings Ltd. and its subsidiaries, including Migdal Sal Domestic Equities, collectively beneficially own 944,049 ordinary shares of TAT Technologies Ltd.
- This represents 7.27% of the company's outstanding ordinary shares as of July 8, 2026.
- The filing is an amendment to a previous Schedule 13G filing.
- The reporting persons are Israeli entities and are filing as insurance companies and investment advisors.
- The shares are held for the benefit of insurance policyholders, portfolio account owners, or members of provident and pension funds.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership without any performance metrics or strategic updates.
Positives
- Significant stake held by a major financial institution, potentially indicating confidence in the company's long-term prospects.
- The filing clarifies the beneficial ownership structure, attributing shares to various subsidiaries managing different funds.
Negatives
- The filing does not contain any financial performance data or forward-looking statements, making it difficult to assess the company's current health or future potential based solely on this document.
Risks
- The filing notes that the ownership rights in the partnership (Migdal Sal Domestic Equities) change frequently according to the partnership agreement, which could lead to shifts in beneficial ownership.
- Each subsidiary operates under independent management and makes its own voting and investment decisions, which could lead to divergent strategies or actions regarding the shares.
Future Outlook
This filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance regarding TAT Technologies' future performance.
Management Comments
- Each of the Subsidiaries manages their own funds and/or the funds of others, including for holders of various insurance policies, members of pension or provident funds, unit holders of mutual funds, portfolio management clients and their nostro accounts.
- Each of the Subsidiaries operates under independent management and makes its own independent voting and investment decisions.
- Neither the filing of this Schedule 13G nor any of its contents shall be deemed to constitute an admission by either the Filing Persons or Subsidiaries that a group exists for purposes of Section 13(d) of the Securities Exchange Act of 1934 or for any other purpose, and each reporting person disclaims the existence of any such group.
- Each of the Filing Persons and Subsidiaries disclaims any beneficial ownership of the securities covered by this report in excess of their actual pecuniary interest therein.
- This Statement shall not be construed as an admission by the Filing Persons or Subsidiaries that they are the beneficial owners of any of the Ordinary Shares covered by this Statement.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes in publicly traded companies. This filing indicates a substantial investment by Migdal Insurance in TAT Technologies, a player in the aerospace and defense industry.
Comparison to Industry Standards
- No specific financial or operational data is provided in this filing to allow for comparison to industry standards or specific companies.
Stakeholder Impact
- Shareholders: The disclosure of a significant stake by a major financial institution may be viewed positively, suggesting institutional interest and potential stability.
- Insurance Policy Holders/Fund Members: Their capital is being invested in TAT Technologies, with the economic interest and beneficial ownership ultimately held for their benefit.
Next Steps
- The reporting persons will continue to file amendments to Schedule 13G as required by regulations.
- Ownership rights in the partnership may change frequently according to the partnership agreement.
Key Dates
| Date | Description |
|---|---|
| 2026-06-30 | Date of Event Which Requires Filing of this Statement |
| 2026-07-08 | Date as of which ordinary shares outstanding were reported on Bloomberg LP |
| 2026-07-22 | Date of Joint Filing Agreement and signatures on Schedule 13G |
Keywords
TAT Technologies, Schedule 13G, Migdal Insurance, Beneficial Ownership, Ordinary Shares, Investment Holdings, Financial Disclosure, Israel
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.